Search | TVST | ARVO Journals

View

Showing 1 – 7 of 7

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2022

Perceived utility of intervention strategies for improving medication adherence in glaucoma

Shervonne Poleon; Lyne Racette

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1656 – A0151. doi:

ARVO Annual Meeting Abstract June 2022

White coat adherence in primary open-angle glaucoma

Nouran Sabbagh; Shervonne Poleon; Lyne Racette

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1648 – A0143. doi:

Articles May 2022

The Usefulness of Assessing Glaucoma Progression With Postprocessed Visual Field Data

PDF

Sampson L. Abu; Shervonne Poleon; Lyne Racette
TAGS: datasets, glaucoma, visual fields, eye
Trans. Vis. Sci. Tech.. 2022; 11(5):5. doi: https://doi.org/10.1167/tvst.11.5.5

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2021

Assessing glaucoma progression with post-processed visual field data

Sampson Listowell Abu; Shervonne Poleon; Lyne Racette

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3380. doi:

ARVO Annual Meeting Abstract June 2021

Racial disparity in the impact of the COVID-19 pandemic on adherence to ocular hypotensive medication among patients of African and European descent

Lyne Racette; Sampson Listowell Abu; Shervonne Poleon; Tracy Thomas; Nouran Sabbagh; Christopher A Girkin

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1979. doi:

ARVO Annual Meeting Abstract June 2021

Group-based trajectory modeling in electronically monitored adherence data in patients with glaucoma

Shervonne Poleon; Sampson Abu; Tracy Thomas; Lyne Racette

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1586. doi:

ARVO Annual Meeting Abstract June 2020

Comparative Assessment of Patient and Provider Perspectives on the Impact of Sociobehavioral Factors on Glaucoma Treatment Adherence

Shervonne Poleon; Lyne Racette; Matthew Fifolt; Yu-Mei Schoenberger-Godwin; Michael D Twa

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):69. doi:

Advertisement